Delivery Order SPE2DB22D3102-SPE2DB25FL2XT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) with a ceiling value of $3,388.33. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $2,084.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,316.60 to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packages) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical supply transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's...
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 3, 2025, by the Defense Logistics Agency for the supply of Varenicline 1 mg tablets (56-count packages) with a ceiling value of $4,757.66. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The delivery order is performed at the vendor's location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,996.74 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets in a quantity of 56 units. The contract was awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under the company's existing federal contract vehicle, with performance to be fulfilled at...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varenicline 1mg tablets (56-count packages) valued at $7,668.62, with completion scheduled for July 30, 2025. This competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. The award was issued under a non-set-aside competitive process, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,703.41 by the Defense Logistics Agency on August 4, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 5, 2025, with performance occurring at the contractor's Conshohocken facility. The award carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a $7,740.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 56 units of 1 mg Varenicline tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for delivery between July 26-27, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this order to supply smoking cessation medications in support of the DLA's...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,055.23, is for the delivery of Varenicline 1 mg tablets over a term ending on March 14, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2XTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Varenicline 1 mg tablets (56-count units) with a contract ceiling value of $4,096.42. This is a firm fixed-price delivery order with no set-aside designation, completed competitively, and is scheduled for ultimate completion by September 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical deliveries covering diverse therapeutic domains including diabetes medications, neurological treatments, pain management products, and specialized medical supplies. Varenicline, a smoking cessation medication, aligns with the company's established role in supplying both brand-name and generic medications to support defense health requirements. The SPE2DX prime contract represents a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/9/25 |